Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Botox plus mirror therapy shows promise for stroke arm stiffness

NCT ID NCT07331844

Symptom relief Sponsor: Fatih Sultan Mehmet Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether adding mirror therapy to Botox injections can better reduce arm spasticity in stroke survivors. Thirty patients who had a stroke at least three months earlier received Botox injections and then either mirror therapy or a sham treatment. Researchers measured muscle tone and arm function before and six months after treatment to see if the combination improves movement and reduces the need for repeat injections.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Botulinum toxin type A (Botox)
What this could lead to
If it works, this combination could reduce arm stiffness and improve movement after stroke, possibly needing fewer Botox injections.
What could go wrong
This is a small, early study with only 30 participants. The results may not apply to everyone, and Botox injections carry risks like muscle weakness or allergic reaction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

May 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years * Diagnosis of unilateral ischemic stroke * Under the routine medical follow-up of the same clinician who plans upper extremity BTX treatment based on standard medical indications * At least 3 months post-stroke * Signed informed consent form * Mini-Mental State Examination (MMSE) score \>24 * Fugl-Meyer Assessment score \<55 * Modified Ashworth Scale (MAS) score of 1-4 Exclusion Criteria: * Any prior BTX-A or other injections administered to the upper extremity Severe cognitive impairment or any mental disorder preventing effective communication * Concurrent enrollment in another experimental treatment program * Visual or motor deficits that would prevent the application of mirror therapy * History of multiple strokes * Presence of neuromuscular pathology in the unaffected extremity * Stroke due to a non-ischemic cause

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ischemic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hemiplegia ischemic stroke spastic hemiplegia stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spastic hemiplegia Stroke

Contacts and locations

Locations

  • Liv hospital Vadistanbul

    Istanbul, Istanbul, 34000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.